Monil Shah

Monil Shah

Corporate Officer/Principal en IMUGENE LIMITED .

Fortuna: 14 751 $ al 31/05/2026

Health Technology
Consumer Services

Perfil

Monil Shah was the founder of Ventrus Biosciences, Inc. (founded in 2011) where he held the title of Vice President-Clinical Research & Development from 2011 to 2014.
He is currently the Chief Business Officer at Imugene Ltd. (since 2021) and the Chief Development Officer at WindMIL Therapeutics, Inc. He previously served as the Chief Operating Officer at IRX Therapeutics, Inc. and Eterna Therapeutics LLC (from 2017 to 2018).
Dr. Shah also held the position of VP-Operations & Clinical Development at LTR Pharma Ltd. Dr. Shah obtained undergraduate and doctorate degrees from Rutgers State University of New Jersey.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
30/06/2025 178.279 ( 0,04 % ) 14 751 $ 31/05/2026

Cargos activos de Monil Shah

EmpresasCargoInicio
IMUGENE LIMITED Corporate Officer/Principal 10/06/2021
Corporate Officer/Principal -

Antiguos cargos conocidos de Monil Shah.

EmpresasCargoFin
Director de Operaciones 01/10/2018
Fundador 01/03/2014
Director de Operaciones -
LTR PHARMA LIMITED Corporate Officer/Principal -
Ver el detalle de la experiencia de Monil Shah.

Formación de Monil Shah.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

13

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology